Newsfeeds - Spark Newswire

2 minute read

Khiron Snatches First Medical Cannabis Contract With One Of Colombia’s Largest Insurance Companies

Today, 2:37 PM

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN)(Frankfurt:A2JMZC), announced that the new Colombian Government has included plant-based medical cannabis products (i.e., Khiron products) in the list of mandatory insurance-covered medications

KHRNF

2 minute read

Khiron Q3 Revenue Declines 24% Sequentially To $2.5M

By Vuk Zdinjak

Today, 2:37 PM

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC) released its financial results for the quarter ended September 30, 2022, revealing revenue of CA$3.4 million ($2.5 million), a 4% decrease compared to CA$3.6 million in the Q3 2021.

KHRNF

12 minute read

15 Global Psychedelics Executives To Keep An Eye On In 2022

By Javier Hasse

Today, 2:37 PM

As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list of some of the top executives in the space to keep an eye on.

ACB

3 minute read

Benzinga Cannabis Award Winners Announced At Chicago Conference, Check Out Full List

By Maureen Meehan

Today, 2:37 PM

For the first time ever, the 15th edition of the Benzinga Cannabis Capital Conference, underway in Chicago September 13-14, presented a series of Benzinga Cannabis Awards.

CSE:JUSH

2 minute read

Marijuana Research Focuses Strictly On Potential Harms From THC, NCCIH Director Says

By Joana Scopel

Today, 2:37 PM

Director of the National Center for Complementary and Integrative Health (NCCIH)

KHRNF

1 minute read

Medical Cannabis Company Khiron, Launching New Products In Europe

By Vuk Zdinjak

Today, 2:37 PM

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC), is launching its new medical product portfolio in Europe.

KHRNF

3 minute read

Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany

By Vuk Zdinjak

Today, 2:37 PM

Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) Q2 2022 total revenue was CA$4.5 million ($3.45 million), up 60% year-over-year, driven by growth in the medical cannabis segment in Colombia and the United Kingdom.

KHRNF

8 minute read

These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?

By Joana Scopel

Today, 2:37 PM

The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies.

AVCNF

4 minute read

Cannabis Dispensary Roundup: Ascend Wellness, Berner’s Cookies, Verano, Khiron, & EmporaPharma

By Nina Zdinjak

Today, 2:37 PM

Ascend Wellness Begins Operations At Third New Jersey Dispensary

AAWH

2 minute read

Khiron Completes Acquisition Of Pharmadrug Production, Expanding Its Presence In Europe

By Vuk Zdinjak

Today, 2:37 PM

Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) has completed the acquisition of Pharmadrug Production GmbH from Pharmadrug Inc. (OTCQB: LMLLF) (CSE:PHRX).

CSE:PHRX